Search
Search Results
##search.searchResults.foundPlural##
-
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3455PDF: 1031HTML: 3015 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2756PDF: 1005HTML: 601 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2403PDF: 1886HTML: 1011 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3843PDF: 1300HTML: 5095Incidence age-standardized rates for HL across the Mediterranean basin: 256 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2263PDF: 1073HTML: 4108Cover Letter: 263Figure 1: 277Figure 2: 269Table 1: 251 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3432PDF: 1005HTML: 4067 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2429PDF: 795HTML: 2155Untitled: 272Untitled: 194Untitled: 228Untitled: 205Untitled: 218Untitled: 239Untitled: 231 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1196PDF: 1236Suppl. Files: 600HTML: 104 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1272PDF: 881HTML: 3421 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
2247PDF: 910HTML: 374 -
PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics
913PDF: 158HTML: 228 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2810PDF: 827HTML: 2333 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2059PDF: 872HTML: 2224Table 1: 230Table 2: 245Table 3: 241Table 4: 239Table 5: 236Tble 6: 233Cover Letter: 247Greene Tab.7: 252 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1562PDF: 999HTML: 262 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
2214PDF: 1177HTML: 10764Untitled: 240 -
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3719PDF: 1624HTML: 4521CoverLetter: 243Figure1: 256 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1950PDF: 1139HTML: 308 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
2033PDF: 869HTML: 257 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
3198PDF: 942HTML: 6619Untitled: 282Untitled: 241Untitled: 259Untitled: 265 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2999PDF: 1173HTML: 486Preferred Reviewers: 251 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1390PDF: 970HTML: 347 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1613PDF: 961HTML: 1025figures: 230table 1: 231table2: 234table3: 239 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2774PDF: 1111HTML: 5124Cover Letter: 201Figure 2: 209Figure 1: 214Figure 3: 238Figure 4: 211Figure Legend: 225Table 1: 239Table 2: 222Table 3: 218 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2633PDF: 1396HTML: 1847CoverLetter: 230 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4434PDF: 1604HTML: 480 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1540PDF: 1326HTML: 527 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1395PDF: 1142HTML: 268 -
I INCREASED RISK OF LYMPHOMA IN MEN INFECTED WITH TUBERCULOSIS
1293PDF: 556HTML: 424 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2340PDF: 781HTML: 361 -







